Paul Knight

Stock Analyst at Keybanc

(2.43)

# 1,407

Out of 4,667 analysts

134

Total ratings

46.51%

Success rate

-1.13%

Average return

Main Sectors:

Healthcare Industrials Technology

Top Industries:

Diagnostics & Research Medical Instruments & Supplies Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices

Stocks Rated by Paul Knight

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CSTL Castle Biosciences	Maintains: Overweight	$28 → $36	$28.45	+26.54%	7	Nov 5, 2024
	DHR Danaher	Maintains: Overweight	$290 → $310	$233.10	+32.99%	9	Oct 23, 2024
	RGEN Repligen	Maintains: Overweight	$210 → $220	$138.90	+58.39%	7	Feb 15, 2024
	WST West Pharmaceutical Services	Maintains: Overweight	$440 → $470	$311.66	+50.81%	10	Feb 13, 2024
	RVTY Revvity	Maintains: Overweight	$110 → $126	$111.34	+13.17%	2	Feb 2, 2024
	CDMO Avid Bioservices	Maintains: Overweight	$20 → $14	$12.22	+14.57%	5	Dec 8, 2023
	TECH Bio-Techne	Maintains: Overweight	$115 → $80	$68.72	+16.41%	8	Nov 1, 2023
	TMO Thermo Fisher	Downgrades: Sector Weight	n/a	$512.84	-	6	Oct 26, 2023
	STVN Stevanato Group	Maintains: Overweight	$35 → $37	$18.27	+102.52%	5	Aug 30, 2023
	MRVI Maravai LifeSciences Holdings	Downgrades: Sector Weight	n/a	$4.82	-	8	Aug 8, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgrades: Sector Weight	n/a	$6.57	-	8	Jul 17, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Sector Weight	n/a	$7.74	-	1	Jul 12, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Overweight	$4	$1.61	+148.45%	1	Jul 12, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgrades: Sector Weight	n/a	$128.57	-	8	May 24, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgrades: Sector Weight	n/a	$44.65	-	3	May 10, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$5 → $7	$2.16	+224.07%	4	Apr 26, 2023
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgrades: Sector Weight	n/a	$59.00	-	5	Dec 19, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$51 → $40	$20.14	+98.61%	6	Sep 15, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$20 → $17	$4.20	+304.76%	5	May 13, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$60 → $30	$25.01	+19.95%	4	May 10, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$390 → $300	$187.90	+59.66%	1	May 5, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$290 → $250	$194.38	+28.61%	1	Apr 28, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Downgrades: Sector Weight	n/a	$2.75	-	2	Mar 14, 2022
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$382 → $441	$187.43	+135.29%	1	Jan 8, 2021
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$222 → $236	$167.59	+40.82%	1	Jan 8, 2021
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$92 → $99	$99.08	-0.08%	1	Jan 8, 2021
	XXXX XXXXXXXXXXXXXXXX Upgrade	Maintains: Overweight	$47 → $55	$17.87	+207.78%	1	Jan 8, 2021
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Sector Weight	n/a	$357.77	-	4	Nov 10, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Sector Weight	n/a	$39.20	-	4	Nov 10, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Initiates: Sector Weight	n/a	$98.59	-	1	Nov 10, 2020
	XXXX XXXXXXXXXXXXXXXX Upgrade	Upgrades: Neutral	n/a	$131.68	-	5	Oct 23, 2017

Castle Biosciences

Nov 5, 2024

Maintains: Overweight

Price Target: $28 → $36

Current: $28.45

Upside: +26.54%

Danaher

Oct 23, 2024

Maintains: Overweight

Price Target: $290 → $310

Current: $233.10

Upside: +32.99%

Repligen

Feb 15, 2024

Maintains: Overweight

Price Target: $210 → $220

Current: $138.90

Upside: +58.39%

West Pharmaceutical Services

Feb 13, 2024

Maintains: Overweight

Price Target: $440 → $470

Current: $311.66

Upside: +50.81%

Revvity

Feb 2, 2024

Maintains: Overweight

Price Target: $110 → $126

Current: $111.34

Upside: +13.17%

Avid Bioservices

Dec 8, 2023

Maintains: Overweight

Price Target: $20 → $14

Current: $12.22

Upside: +14.57%

Bio-Techne

Nov 1, 2023

Maintains: Overweight

Price Target: $115 → $80

Current: $68.72

Upside: +16.41%

Thermo Fisher

Oct 26, 2023

Downgrades: Sector Weight

Price Target: n/a

Current: $512.84

Upside: -

Stevanato Group

Aug 30, 2023

Maintains: Overweight

Price Target: $35 → $37

Current: $18.27

Upside: +102.52%

Maravai LifeSciences Holdings

Aug 8, 2023

Downgrades: Sector Weight

Price Target: n/a

Current: $4.82

Upside: -

Jul 17, 2023

Downgrades: Sector Weight

Price Target: n/a

Current: $6.57

Upside: -

Jul 12, 2023

Initiates: Sector Weight

Price Target: n/a

Current: $7.74

Upside: -

Jul 12, 2023

Initiates: Overweight

Price Target: $4

Current: $1.61

Upside: +148.45%

May 24, 2023

Downgrades: Sector Weight

Price Target: n/a

Current: $128.57

Upside: -

May 10, 2023

Downgrades: Sector Weight

Price Target: n/a

Current: $44.65

Upside: -

Apr 26, 2023

Maintains: Overweight

Price Target: $5 → $7

Current: $2.16

Upside: +224.07%

Dec 19, 2022

Downgrades: Sector Weight

Price Target: n/a

Current: $59.00

Upside: -

Sep 15, 2022

Maintains: Overweight

Price Target: $51 → $40

Current: $20.14

Upside: +98.61%

May 13, 2022

Maintains: Overweight

Price Target: $20 → $17

Current: $4.20

Upside: +304.76%

May 10, 2022

Maintains: Overweight

Price Target: $60 → $30

Current: $25.01

Upside: +19.95%

May 5, 2022

Maintains: Overweight

Price Target: $390 → $300

Current: $187.90

Upside: +59.66%

Apr 28, 2022

Maintains: Overweight

Price Target: $290 → $250

Current: $194.38

Upside: +28.61%

Mar 14, 2022

Downgrades: Sector Weight

Price Target: n/a

Current: $2.75

Upside: -

Jan 8, 2021

Maintains: Overweight

Price Target: $382 → $441

Current: $187.43

Upside: +135.29%

Jan 8, 2021

Maintains: Overweight

Price Target: $222 → $236

Current: $167.59

Upside: +40.82%

Jan 8, 2021

Maintains: Overweight

Price Target: $92 → $99

Current: $99.08

Upside: -0.08%

Jan 8, 2021

Maintains: Overweight

Price Target: $47 → $55

Current: $17.87

Upside: +207.78%

Nov 10, 2020

Initiates: Sector Weight

Price Target: n/a

Current: $357.77

Upside: -

Nov 10, 2020

Initiates: Sector Weight

Price Target: n/a

Current: $39.20

Upside: -

Nov 10, 2020

Initiates: Sector Weight

Price Target: n/a

Current: $98.59

Upside: -

Oct 23, 2017

Upgrades: Neutral

Price Target: n/a

Current: $131.68

Upside: -